There have been quite a few regulatory changes in the last few years such as the new drug registration process and the suppression of the local…
In Conversation
This is your 3rd interview with Focus Reports. What would you say has been the biggest change that has shaped the pharmaceutical industry since we last…
This is your third interview with Focus Reports. In 2004 and 2008 you were Director of AMIIF, before that you were Director of ANAFAM, and now…
The pharmaceutical industry in Asia is undergoing a period of specialization with R&D booming in places like Australia, Singapore and South Korea and manufacturing in places…
Mr. Sardi, Exec-VP of Tecnoquímicas, the No. 1 producer and distributor of generic pharmaceutical drugs in Colombia, explains what makes Tecnoquímicas different from their contemporaries and…
¿Cual fue la visión detrás de la creación de IBC y Dromex? Nuestro negocio original consistía en representar comercialmente a los fabricantes de APIs europeos. Esto…
¿Cuál es la historia de Laboratorios Poen y como ha crecido en los últimos años? Poen se inició siendo un pequeño laboratorio de capitales nacionales dedicado…
You were General Manager of Pfizer Peru and Pfizer Venezuela before taking on the challenge of the Argentinean market. How difficult was the experience of adjusting…
¿Porque fue creado en Ministerio de Ciencia y Tecnología, con que visión? Muchos países están aportando importancia a la ciencia y tecnología y representa la razón…
When we spoke to Javier Lombar of IMS Argentina, he explained that a lot of multinational companies use Argentina as a base for regional operations. How…
Through your work as member of the Council of the IFPMA, as well as FIFARMA, and CAEMe, you must have a very developed and unique perspective…
The appointment of Lino Barañao and the establishment of the Ministry of Science and Technology suggest that the government has realised what a large role innovation…
